Skip to main content
Clinical Trials/NL-OMON38649
NL-OMON38649
Completed
Not Applicable

Validation of a questionnaire algorithm for 'allergic contact dermatitis' with the Repeated Open Application Test (ROAT) for fragrances. - Validation of a questionnaire algorithm for 'allergic contact dermatitis'

niversitair Medisch Centrum Groningen0 sites20 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
allergic contact dermatitis
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria for the Fragrance Mix positive subjects:
  • \- Participated in the EDEN fragrance study and gave permission to be re\-invited for a follow\-up study
  • \- Positive patch\-test to FM I and/or FM II
  • \- Adulthood (18 years and older)
  • \- Legal competent
  • \- Understands Dutch;Inclusion criteria for the FM\-negative subjects (controls):
  • \- Participation in the EDEN fragrance study and gave permission to be re\-invited for follow\-up studies
  • \- Negative patch test results to all fragrances including fragrance mix I and fragrance mix II
  • \- Matched to the FM\-positive group for age and gender
  • \- Adulthood (18 years of age or older)

Exclusion Criteria

  • Exclusion criteria for both groups are:
  • \- Skin anomalies on the forearms and back such as active eczema
  • \- Immunosuppressive medication during the study or in the four weeks before inclusion (oral corticosteroids, cyclosporine, methotrexate, azathioprine, biologicals)
  • \- Pregnancy (wish)
  • \- Legally incompetent
  • \- Difficulty understanding oral and written information in Dutch.
  • \- Angry back in the past (extreme hypersensitivity to pacth test resulting in a red, itching back or multiple false\-positive patch test reactions)

Outcomes

Primary Outcomes

Not specified

Similar Trials